Market revenue in 2021 | USD 1,129.7 million |
Market revenue in 2030 | USD 2,310.5 million |
Growth rate | 8.3% (CAGR from 2021 to 2030) |
Largest segment | Dermal drug delivery |
Fastest growing segment | Dermal Drug Delivery |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dermal Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery |
Key market players worldwide | Bayer AG, Cipla Ltd DR, GSK PLC ADR, Johnson & Johnson, Novartis AG ADR, Bausch Health Companies Inc, Hisamitsu Pharmaceutical Co Inc, Merck & Co Inc, Glenmark Pharmaceuticals, MedPharm |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to topical drugs market will help companies and investors design strategic landscapes.
Dermal drug delivery was the largest segment with a revenue share of 53.71% in 2024. Horizon Databook has segmented the Sweden topical drugs market based on dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery, nasal drug delivery covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden topical drugs market , including forecasts for subscribers. This country databook contains high-level insights into Sweden topical drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account